Shandong Bailong Chuangyuan Bio-Tech (605016.SH) plans to establish Shandong Bailong Chuangyuan Bio-Tech (Nanjing) Biotechnology Co., Ltd.

15:40 11/02/2026

Bailong Innovation Park (605016.SH) announced that, based on its development strategy and operational needs, the company has invested 10 million yuan using its own funds to establish a wholly-owned subsidiary, Bailong Innovation Park (Nanjing) Biotechnology Co., Ltd. (referred to as "Nanjing Bailong"). The company directly holds 100% of the shares of Nanjing Bailong.

Shandong Bailong Chuangyuan Bio-Tech (605016.SH) issued an announcement that, based on their development strategy and business needs, they will invest 10 million yuan of self-owned funds to establish a wholly-owned subsidiary, Shandong Bailong Chuangyuan Bio-Tech (Nanjing) Biotechnology Co., Ltd. (referred to as "Nanjing Bailong"). The company will directly hold 100% of the shares of Nanjing Bailong.

Zhejiang Sunflower Great Health (300111.SZ): Some products from Beide Pharmaceutical are expected to be selected for centralized procurement.

CGN POWER (01816) has successfully completed the issuance of 2 billion yuan in ultra-short-term financing.

Lens Technology (06613) cancels 5,586,700 shares of inventory stock.

Zhejiang Sunflower Great Health (300111.SZ): Some products from Beide Pharmaceutical are expected to be selected for centralized procurement.

CGN POWER (01816) has successfully completed the issuance of 2 billion yuan in ultra-short-term financing.

Lens Technology (06613) cancels 5,586,700 shares of inventory stock.